Condition
Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) clinical trials and research
Research outlook What's coming for Chronic lymphocytic leukemia: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) clinical trials that are recruiting, at sites in 2 countries (most in Italy (1), China (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
LEF1 levels as a diagnostic and survival marker in CLL/SLL
We will test whether measuring LEF1 protein in lymph node, bone marrow, or other tissue samples can help diagnose and predict outcomes for adults with CLL/SLL.
-
Using venetoclax to treat CLL patients on BTK inhibitors
This study is testing if adding venetoclax to the treatment of chronic lymphocytic leukemia (CLL) patients already on BTK inhibitors can help improve their condition after six months of treatment.
Quick answers
How many Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.